Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#4473 Somatostatin analogue delayed the recrudescence of stomach NET: A real-world study

Introduction: Type 1 gastric NENs (g-NENs) are common and relapse easily. Somstostatin analogues (SSAs) can inhibit gastrin secretion and cell proliferation. While the usage of SSAs in g-NENs is still controversial.

Conference:

Presenting Author: Cai W

Authors: Cai W, Zhang J, Ge W, Hu H,

Keywords: somatostatin analogue, Type 1 gastric NEN, real-world study,

#4354 Analysis of gastric NENS in the Czech neuroendocrine tumour registry (2009-2024)

Introduction: Czech Neuroendocrine Tumour Registry is collecting data of NEN patients and their treatment since 2009. We have already analysed SI NENs, pancreatic and thymic NENs. Now we focused on analysis of gastric NENs.

Conference:

Presenting Author:

Authors: Barkmanova J, Sedlackova E,

Keywords: registry, gastric neuroendocrine neoplasia,

#4067 Malignancy of gastric neuroendocrine tumors is higher than pancreatic neuroendocrine tumors in Chinese population – Characterisation and analysis of factors

Introduction: Based on a large-scale epidemiological survey with a total of 2010 cases of neuroendocrine tumors (NENs) in the Chinese population from multiple centers, we observed that the malignancy of gastric NENs (G3, accounting for 67.2%) is higher than that of pancreatic NENs(G3, accounting for 9.9%).

Conference:

Presenting Author: Sun W

Authors: Sun W, Fan J,

Keywords: gastric NEN, pancreatic NEN, epidemiology, multi-center,

#2711 Gastric Neuroendocrine Neoplasms: Clinical Management and Outcomes in a Cohort of 54 Patients

Introduction: Gastric NENs are increasingly being diagnosed at endoscopy. The majority of these are type 1 gastric NEN. However, around 10-20% can be type 3 or type 4 Gastric NENs.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Victor A

Authors: Victor A, Ramage J, Cope J, Maclean R, Hayee B,

Keywords: gastric NENs, EMR, ESR, Outcomes,

#2709 Endoscopic Management and Outcomes of Gastro-Duodenal Neuroendocrine Tumours

Introduction: Gastric and duodenal neuroendocrine tumours are increasing in incidence. ENETS guidelines suggest endoscopic resection of type 1 gastric NENs over 10mm and consider endoscopic resection for duodenal NENs. However, the endoscopic techniques are not clearly mandated. There, is evidence to suggest endoscopic mucosal dissection has higher incidence of R0 resections compared with polypectomy or EMR alone.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Victor A

Authors: Victor A, Pizanias M, Gulati S, Gunasingham N, Ramage J,

Keywords: EMR, ESD, gastric NENS, duodenal NENS,